First systematic single-cell analysis of transcriptional variation within the T cell population

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Immune cells play important roles in mediating allograft rejection and tolerance after cardiac transplantation. However, immune cell heterogeneity at the single-cell level, and how immune cell states shape transplantation immunity, remain incompletely characterized.

The authors of this article performed single-cell RNA sequencing (scRNA-seq) on immune cells in LNs from a mouse syngeneic and allogeneic cardiac transplantation model. Nine T cell clusters were identified through unsupervised analysis. Pathway enrichment analysis was used to explore the functional differences among cell subpopulations and to characterize the metabolic heterogeneity of T cells.

The transcriptional landscape of immune cells was determined, particularly T cells, and their metabolic transcriptomes in LNs during mouse cardiac transplantation. On the basis of molecular and functional properties, we also identified T cell types associated with transplantation-associated immune processes, including cytotoxic CD8+ T cells, activated conventional CD4+ T cells, and dysfunctional Tregs. The contribution of JunB to the induction of Th17 cell differentiation and restriction of Treg development was further elucidated, and the authors identified that HIF-1a participates in T cell metabolism and function.

The first systematic single-cell analysis of transcriptional variation within the T cell population is presented in this article, providing new insights for the development of novel therapeutic targets for allograft rejection.

Journal reference:

Tong, Z., et al. (2023) Single-Cell RNA Sequencing Maps Immune Cell Heterogeneity in Mice with Allogeneic Cardiac Transplantation. Cardiovascular Innovations and Applications.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
You might also like...
Novel treatment targets against natural killer/T-cell lymphoma identified